Loading Events

« All Events

  • This event has passed.

Anavex President & CEO Christopher U. Missling, PhD, to present preclinical data on ANAVEX 2-73™ at the Epilepsy Foundation’s Antiepileptic Drug Trials XIV Conference on May 19.

May 19, 2017 @ 3:10 PM

Anavex President & CEO Christopher U. Missling, PhD, will be presenting preclinical data on ANAVEX 2-73™ at the Epilepsy Foundation’s Antiepileptic Drug Trials XIV Conference on May 19, 2017.

May 17-19, 2017 | Turnberry Isle Miami Hotel  | Aventura, Florida

Antiepileptic Drug Trials XIV Conference | May 2017
Friday, May 19, 2017
ANAVEX 2-73, A Clinical Candidate for Neurodevelopmental Disorders
Christopher Missling, PhD, Anavex Life Sciences Corp.  

Venue

Turnberry Isle Miami Hotel
19999 West Country Club Drive
Aventura, FL 33180 United States
+ Google Map
Phone:
305.932.6200
Website:
http://www.turnberryislemiami.com/

Organizer

Epilepsy Foundation
Website:
http://www.epilepsy.com